STARD13 抗体 (AA 516-679) (FITC)
-
- 抗原 See all STARD13 抗体
- STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
-
抗原表位
- AA 516-679
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This STARD13 antibody is conjugated to FITC
- 应用范围
- 请咨询
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human StAR-related lipid transfer protein 13 protein (516-679AA)
- 亚型
- IgG
- Top Product
- Discover our top product STARD13 Primary Antibody
-
-
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
- 别名
- STARD13 (STARD13 产品)
- 别名
- ARHGAP37 antibody, DLC2 antibody, GT650 antibody, LINC00464 antibody, RGD1564816 antibody, StAR related lipid transfer domain containing 13 antibody, StAR-related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer domain containing 13 antibody, STARD13 antibody, Stard13 antibody
- 背景
-
Background: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells.
Aliases: 46H23.2 antibody, ARHGAP37 antibody, Deleted in liver cancer 2 protein antibody, Deleted in liver cancer protein 2 antibody, DLC-2 antibody, DLC2 antibody, GT650 antibody, Rho GTPase activating protein on chromosome 13q12 antibody, Rho GTPase-activating protein antibody, STA13 antibody, STA13_HUMAN antibody, StAR related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer protein 13 antibody, StARD13 antibody, START domain-containing protein 13 antibody
- UniProt
- Q9Y3M8
-